Connection

Mitzi Nagarkatti to Chemokine CCL2

Back to Details
This is a "connection" page, showing publications Mitzi Nagarkatti has written about Chemokine CCL2.
Mitzi Nagarkatti
Connection Strength
0.620
Chemokine CCL2
  1. Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1. J Leukoc Biol. 2014 Apr; 95(4):609-19.
    View in: PubMed
    Score: 0.432
  2. Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB/N strain. Int J Obes (Lond). 2016 05; 40(5):844-51.
    View in: PubMed
    Score: 0.124
  3. Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity. Sci Rep. 2017 06 02; 7(1):2707.
    View in: PubMed
    Score: 0.034
  4. 3,3'-Diindolylmethane attenuates LPS-mediated acute liver failure by regulating miRNAs to target IRAK4 and suppress Toll-like receptor signalling. Br J Pharmacol. 2015 Apr; 172(8):2133-47.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.